Obstetrics, Gynecology and Reproductive Biology Research
Ironwood Study
A Phase 2 Study of IW‑3300 for the Treatment of Bladder Pain in Subjects with Interstitial Cystitis/Bladder Pain Syndrome
AGE: 18+ years old
GENDER: Female
HEALTHY PARTICIPANTS: No
GENDER: Female
HEALTHY PARTICIPANTS: No
TYPE: Interventional Treatment
CONDITION: Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS)
CONDITION: Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS)
LOCATION: University Hospitals Medical Centers
COMPENSATION: Yes
COMPENSATION: Yes
Learn More About This Research Study
For more information, please contact the study coordinator, Alyssa Mason, PhD at 440-995-3811 or by completing the form below.
Study Purpose
The purpose of this study is to assess the efficacy, safety, and tolerability of IW‑3300, an investigational drug for the treatment for interstitial cystitis/bladder pain syndrome (IC/BPS) administered once daily as a rectal foam.
Who Can Participate
Premenopausal women 18 years of age or older with interstitial cystitis/bladder pain syndrome may be eligible for this study.
- STUDY20230606
- SITE00002000